Skip to the answer
BPC care pathwayReading list

Leave room to pause

Pause when the explanation does not add up

Pause the decision when a claim does not match the record, or when the person answering changes the subject.

A claim of approval needs proof

FDA is the US Food and Drug Administration, the medicine regulator.

No US medical use of BPC-157 had approval when checked September 28, 2026.

Compounded medicines also lack FDA approval; calling a made-to-order product FDA approved is false.

A research label is not a care check

A research use only label does not establish that FDA has reviewed a BPC-157 product for people.

In warning letters reviewed September 26, 2026, FDA said such labels did not excuse sales of unapproved drugs intended for human treatment.

Those letters set out FDA's allegations against particular businesses, rather than court judgments.

A drug identification number is not approval

A National Drug Code is an identification number in a drug directory.

FDA says a code or a drug listing does not establish approval; the rule was checked September 26, 2026.

Ask for the approval record itself if approval is being claimed.

Missing names leave the checks unfinished

Ask who would assess you and who would prepare any proposed medicine. If the answer stays vague, leave the choice open.

You can end a sales conversation without ending your search for care. Bring the unanswered questions to another assessment.

Why this answer?

Keep the limits in view

A research label, registration and a directory code do not stand in for approval. Enforcement letters are allegations about the businesses addressed.

Read the records for this answer